Heartburn drug suspended from sale - US retailer CVS has become the latest to suspend the sale of a heartburn drug being investigated for links to cancer. The move comes after concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European Union are investigating. Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine.
The Riviera is once again facing heavy rain and storms tonight and tomorrow
Read More
1.9 million people in France have received income support, known as the RSA, in 2018. Figures published have shown that the number of beneficiaries ha...
Read More
An earth tremor has been reported in the Pyrenees. The tremor with a magnitude of 3.8 occurred in the early hours of this morning. Local authorities r...
Read More
According to a survey published today four out of five teenagers in the world do not get enough physical activity, especially girls. ...
Read More
The association Monaco Disease Power has organized a conference this Saturday the 23rd November.
Read More
